PEMETREXED 910 MG QS NS IVPB recalled over sterility concerns
- Recall date
- June 12, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Infusion Options, Inc. recalls PEMETREXED 910 MG QS 100 ML NS IVPB; PEMETREXED 940 mg QS 100 ml NS IVPB; PEMETREXED 1000 mg QS 100 ml 0.9% NACL IVPB;…
- Recall number
- D-1803-2019
- FDA classification
- Class II
- Brand / firm
- Infusion Options, Inc.
- Sold / distributed
- NY only
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PEMETREXED 910 MG QS 100 ML NS IVPB; PEMETREXED 940 mg QS 100 ml NS IVPB; PEMETREXED 1000 mg QS 100 ml 0.9% NACL IVPB; PEMETREXED 490 MG /100 ml NS IVPB; PEMETREXED 800 mg/ 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
Get recall alerts
Free email alert whenever Infusion Options, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Infusion Options, Inc.